CTCA Southwestern ( Site 0074) — Tulsa, Oklahoma

CTCA Southwestern ( Site 0074) is a clinical research site located in Tulsa, Oklahoma, United States 74133.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

CTCA Southwestern ( Site 0074) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Breast Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CTCA Southwestern ( Site 0074)?

CTCA Southwestern ( Site 0074) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CTCA Southwestern ( Site 0074) conducted?

CTCA Southwestern ( Site 0074) has 1 clinical trials on record, with 1 currently active. Their work covers Breast Cancer.

Is CTCA Southwestern ( Site 0074) accredited by Crixeo Health?

CTCA Southwestern ( Site 0074) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CTCA Southwestern ( Site 0074)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.